PMCTPharmaCountry
    Inicio

Actualizaciones regulatorias

Novedades regulatorias de FDA, EMA, TGA y organismos globales

#ANAGRELIDE ×

UPDATED
Actualizaciones regulatorias
30 ago 2026•1 min de lectura
FDA Approves ANAGRELIDE (ANDA076811)
FDA has approved the generic oral capsule ANAGRELIDE under ANDA076811, covering 0.5 mg and 1 mg strengths, sponsored by Novitum Pharma and manufactured by ANI Pharmaceuticals.